Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Development and validation of a novel mitophagy-related gene prognostic signature for glioblastoma multiforme

Fig. 5

Validation of risk model in CGGA cohort. A Distribution of patients according to risk model in CGGA cohort. B Principal component analysis (PCA) plot of GBM patient based on risk model. C The survival status and time of patient with GBM. (Low-risk: on the left side of dotted line. High-risk on the right side of dotted line). D Kaplan-meier (KM) survival analysis of patients in low-risk and high-risk groups. E ROC curve for predicting efficiency of the risk model. F Univariate Cox regression analysis of risk score in CGGA cohort. G Multivariate Cox regression analysis of risk score in CGGA cohort

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us